-- digiRX™ - Software to streamline and digitize the prescription
handling process to eliminate handwritten errors, prescription loss,
prescription forgery and improve the speed of patient information
verification and prescription fulfillment.
-- digiReAuth™ - Prescription reauthorization software used in
conjunction with the company's call center, to process patient prescription
reauthorizations digitally between the clinic and pharmacy, reducing
physician workload and speeding up the process for the patient.
-- digiPRN™ - Software connecting the Pharmacist to the Doctor's
office for the process of receiving digital prescriptions. Pharmacists no
longer need to worry about the security of the prescription since the
doctor and pharmacist are on the same secure network.
To be added to digiMedical's corporate e-mail list to receive company
updates, please send an e-mail to ir@digimedical.com.
About digiMedical Solutions, Inc.™ (www.digiMedical.com)
digiMedical Solutions, Inc.™ is a pharmacy and medical technology
company focused on developing next generation, digital medical technology
with an emphasis on digital prescriptions (d-Prescriptions) that closely
align the doctor, pharmacist and patient. The company's planned growth will
come from three channels: direct marketing of the company's wireless based
d-prescription technology to physicians, direct marketing of the company's
digital call center services for refills and reauthorization and partnering
with independent pharmacy chains to focus sales with the technology suite.
Forward-Looking Statement
Statements included in this press release which are not historical in
nature, are intended to be, and are hereby identified as "Forward-Looking
Statements" for purposes of safe harbor provided by Section 21E of the
Securities Exchange Act of 1934, as amended. Forward-Looking Statements may
be identified by words including "anticipate," "await," "envision,"
"foresee," "aim at," "believe," "intends," "estimates" including without
limitation, those relating to the company's future business prospects, are
subject to certain risks and uncertainties that could cause actual results
to differ materially from those indicated in the Forward-Looking
Statements. Readers are directed to the company's filings with the U.S.
Securities and Exchange Commission.
Contact Information: Contact: digiMedical Solutions, Inc. Investor Relations 214-722-3029 ir@digimedical.com www.digimedical.com